Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Will Tesla Motors Inc (TSLA)’s Stock Offering and Expansion Plans Change Hedge Funds’ Mind?

Page 1 of 2

Tesla Motors Inc (NASDAQ:TSLA)‘s stock edged up in pre-market and opened the Thursday trading session at around 2.50% in green amid news that the company plans to offer 2.10 million shares in a public offering. Moreover, as Tesla stated in its filing with the SEC regarding the offering, CEO Elon Musk is interested in buying up to 83,974 shares in the offering for an aggregate purchase price of around $20 million. Underwriters for the offering will be Goldman Sachs & Co., Morgan Stanley, J.P. Morgan, Deutsche Bank Securities, and Bank of Americal Merrill Lynch. Tesla plans to obtain around $500 million in gross proceeds from the sale of shares and will offer an additional $75 million worth of stock as over-allotment options. The net proceeds will be used to accelerate Tesla’s growth in the US and internationally, which will include the expansion of its Supercharger network, stores and service centers, as well as the development and production of Model 3 vehicle.

Will Tesla Motors Inc (TSLA) CEO make Ford Motor Company (F) CEO Jealous with this Payout?

Tesla Motors Inc (NASDAQ:TSLA)’s stock is up by almost 10% year-to-date and has been fluctuating in the last weeks on the back of a string of news from the company. At the beginning of July, the company announced that it had record deliveries of 11,507 Model S vehicles during the second quarter, which represented a 52% annual growth. Last week it disclosed its financial results for the second quarter, which included revenue of $1.20 billion, up by 40% on the year and a net loss of $0.49 per share, which beat the estimates of a loss of $0.59 per share. However, in its letter to shareholders for the second quarter, Tesla also cut its delivery outlook for the full year, which sent the stock 12% lower on August 6. The company had previously predicted to deliver 55,000 new Model S and Model X vehicles, but later restated that this number may be short by as much as 5,000 units.

Tesla Motors is a very controversial stock, which can also be noticed by the large differences of opinion among analysts. For example, S&P Equity Research downgraded the stock to ‘Sell’ last week after the earnings release, while Credit Suisse reiterated its ‘Outperform’ rating and the price target of $325. Moreover, Bank of America Merill Lynch also reiterated ‘Underperform’ rating with a price target of $180, among others.

However, another important metric that could help clear out the situation around Tesla Motors Inc (NASDAQ:TSLA) is the hedge fund sentiment that we follow at Insider Monkey. We base it on the popularity of the stock among a pool of over 700 hedge funds, as well as, the aggregate value of these funds’ long positions in the company. We determined that hedge funds are very good at picking individual stocks, even though their average returns have slumped in the past years. However, we also determined through empirical research that the best-performing ideas of hedge funds are their small-cap picks, which are usually priced less inefficiently and have a better chance to be traded at a discount. Our small-cap strategy focuses on 15 most popular small-cap stocks among hedge funds from our database and it was launched in August 2012. Since the launch, this strategy generated cumulative returns of over 123%, beating the market by around 65 percentage points (see more details here).

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!